TGFB1 and colitis: In line with this, mesenchymal stem cells (MSCs) transplantation to mice that were subjected to DSS-induced colitis reduced intestinal inflammation severity, and this effect was suggested to occur through the recruitment of macrophages with high TGF-β expression levels [111].